Header Logo

John Stock

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Raloxifene Hydrochloride
12
2013
19
1.650
 Why?
Osteoporosis, Postmenopausal
12
2013
48
1.450
 Why?
Bone Density Conservation Agents
6
2013
44
0.970
 Why?
Selective Estrogen Receptor Modulators
8
2010
18
0.740
 Why?
Fractures, Bone
7
2010
143
0.720
 Why?
Alendronate
5
2013
14
0.700
 Why?
Spinal Fractures
5
2008
38
0.570
 Why?
Bone Density
8
2013
137
0.410
 Why?
Osteoporosis
3
2008
108
0.320
 Why?
Cardiovascular Diseases
3
2008
848
0.230
 Why?
Breast Neoplasms
5
2013
1213
0.210
 Why?
Double-Blind Method
5
2008
744
0.180
 Why?
Estrogen Replacement Therapy
3
2006
81
0.160
 Why?
Femur Neck
3
2005
12
0.130
 Why?
Diphosphonates
3
2010
33
0.120
 Why?
Middle Aged
10
2013
17921
0.100
 Why?
Absorptiometry, Photon
2
2005
76
0.100
 Why?
Aged
10
2013
14662
0.100
 Why?
Osteoporotic Fractures
1
2013
36
0.100
 Why?
Female
14
2013
33382
0.090
 Why?
Treatment Outcome
5
2010
5696
0.090
 Why?
Thiophenes
1
2010
30
0.080
 Why?
Risk
3
2008
379
0.080
 Why?
Piperidines
1
2010
66
0.080
 Why?
Humans
16
2013
64283
0.080
 Why?
Mortality
1
2010
161
0.070
 Why?
Lumbar Vertebrae
3
2005
168
0.070
 Why?
Postmenopause
4
2010
238
0.070
 Why?
Safety
1
2006
145
0.060
 Why?
Calcitonin
2
2004
17
0.060
 Why?
Venous Thrombosis
1
2006
112
0.060
 Why?
Risk Reduction Behavior
1
2005
120
0.060
 Why?
Clinical Trials as Topic
1
2008
460
0.060
 Why?
Decision Support Techniques
1
2006
192
0.050
 Why?
Randomized Controlled Trials as Topic
3
2004
788
0.050
 Why?
Vitamin D
2
2004
139
0.050
 Why?
Bone and Bones
1
2005
145
0.050
 Why?
Cerebrovascular Disorders
1
2004
81
0.050
 Why?
Follow-Up Studies
2
2010
2482
0.050
 Why?
Hip Fractures
1
2004
77
0.050
 Why?
Calcium
2
2004
580
0.050
 Why?
Estrogen Receptor Modulators
1
2002
8
0.050
 Why?
Medical Records
1
2002
138
0.040
 Why?
Logistic Models
1
2004
1270
0.040
 Why?
Health Care Surveys
1
2002
289
0.040
 Why?
Aged, 80 and over
2
2010
5528
0.040
 Why?
Research Design
1
2002
583
0.040
 Why?
Placebos
2
2010
72
0.030
 Why?
Incidence
2
2008
1385
0.020
 Why?
Bone Resorption
1
2010
45
0.020
 Why?
Women's Health
1
2013
374
0.020
 Why?
Comorbidity
1
2013
1119
0.020
 Why?
Adult
1
2004
17134
0.020
 Why?
Cohort Studies
1
2013
2605
0.020
 Why?
Coronary Disease
1
2008
246
0.020
 Why?
Time Factors
2
2005
3725
0.020
 Why?
Femoral Neck Fractures
1
2005
12
0.010
 Why?
Poisson Distribution
1
2005
53
0.010
 Why?
United States
2
2013
7923
0.010
 Why?
Bone Remodeling
1
2005
25
0.010
 Why?
Fracture Healing
1
2005
26
0.010
 Why?
Cost-Benefit Analysis
1
2006
318
0.010
 Why?
Multicenter Studies as Topic
1
2004
151
0.010
 Why?
Age Distribution
1
2004
258
0.010
 Why?
Hormones
1
2004
60
0.010
 Why?
Estrogens
1
2004
116
0.010
 Why?
Population Surveillance
1
2004
209
0.010
 Why?
Global Health
1
2004
183
0.010
 Why?
Proportional Hazards Models
1
2005
735
0.010
 Why?
Risk Factors
2
2004
5341
0.010
 Why?
Disease Notification
1
2002
5
0.010
 Why?
Patient Selection
1
2004
487
0.010
 Why?
Reference Values
1
2002
333
0.010
 Why?
Mass Screening
1
2006
693
0.010
 Why?
Guidelines as Topic
1
2002
158
0.010
 Why?
Retrospective Studies
1
2013
6740
0.010
 Why?
Prevalence
1
2004
1407
0.010
 Why?
Biomarkers
1
2004
1431
0.010
 Why?
Prospective Studies
1
2004
3318
0.010
 Why?
Surveys and Questionnaires
1
2002
2738
0.010
 Why?
Stock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_